Prestige Consumer Healthcare
PBH
#3956
Rank
C$4.08 B
Marketcap
C$82.97
Share price
-0.61%
Change (1 day)
-29.58%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): C$5.72

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is C$5.62. In 2024 the company made an earnings per share (EPS) of C$5.95 an increase over its 2023 EPS that were of C-$2.23.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$5.72-3.87%
2024C$5.95-367.08%
2023C-$2.23-138.33%
2022C$5.8111.7%
2021C$5.2013.6%
2020C$4.58-651.67%
2019C-$0.83-148.78%
2018C$1.70-83.29%
2017C$10.19437.23%
2016C$1.90-34.13%
2015C$2.8852.94%
2014C$1.88-8.11%
2013C$2.05
2011C$1.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
C$4.98-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$2.38-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
C-$41.00-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.45 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
C$1.69-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
C$10.19 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
C$9.73 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
C$0.55-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
C$8.87 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.15 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA